Activatable prodrug for controlled release of an antimicrobial peptide via the proteases overexpressed in Candida albicans and Porphyromonas gingivalis
Theranostics · 2024
DOI: 10.7150/thno.91165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Lubna Amer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Program in Materials Science and Engineering, University of California, San Diego, La Jolla, CA 92093, United States. Hauptthemen laut MEDLINE: Prodrugs, Metal Nanoparticles, Periodontal Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIDCR NIH HHS, NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program in Materials Science and Engineering, University of California, San Diego, La Jolla, CA 92093, United States.
- Department of NanoEngineering, University of California, San Diego, La Jolla, CA 92093, United States.
- Department of Radiology, University of California, San Diego, La Jolla, CA 92093, United States.
Förderung
- NINDS NIH HHS
- NIDCR NIH HHS
- NIH HHS
Zitieren
APA
Amer, L., Retout, M., & Jokerst, J. V. (2024). Activatable prodrug for controlled release of an antimicrobial peptide via the proteases overexpressed in Candida albicans and Porphyromonas gingivalis. Theranostics. https://doi.org/10.7150/thno.91165
Vancouver
Amer L, Retout M, Jokerst JV. Activatable prodrug for controlled release of an antimicrobial peptide via the proteases overexpressed in Candida albicans and Porphyromonas gingivalis. Theranostics. 2024. doi:10.7150/thno.91165
BibTeX
@article{Amer2024,
author = {Amer, Lubna and Retout, Maurice and Jokerst, Jesse V},
title = {Activatable prodrug for controlled release of an antimicrobial peptide via the proteases overexpressed in Candida albicans and Porphyromonas gingivalis},
journal = {Theranostics},
year = {2024},
doi = {10.7150/thno.91165}
}
EUVIMED